Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Press Release
Jul 12, 2017
| Erica Klinger
AAM Applauds House Passage of FDA User Fee Reauthorization
Amicus Brief
Jul 10, 2017
| Erica Klinger
MOMENTA PHARMACEUTICALS, INC. v. BRISTOL-MYERS SQUIBB COMPANY
Press Release
Jul 10, 2017
| Erica Klinger
Rachel Sher Joins Association for Accessible Medicines
Video
Jul 7, 2017
| Erica Klinger
Stop Big Pharma Patent Abuse
Press Release
Jul 6, 2017
| Erica Klinger
AAM Requests Federal Injunction to Block Maryland’s Unconstitutional Drug Price Law
Press Release
Jun 28, 2017
| Erica Klinger
More Competition, Access to Lower Cost Generic Drugs is a Win for Patients
Report
Jun 17, 2017
| Erica Klinger
REMS and Restricted Distribution Programs
Fact Sheet
Jun 9, 2017
| Erica Klinger
Expanding Patient Access by Preserving Drug Patent Challenges
Blog
Jun 8, 2017
| Erica Klinger
2017 Generic Drug Access and Savings in the U.S. Report
Blog
Apr 27, 2017
| Erica Klinger
Group Letter in Support of CREATES Act
Press Release
Apr 27, 2017
| Erica Klinger
Bill to Lower Drug Prices Gains Bipartisan Momentum in the House and Senate
Press Release
Apr 27, 2017
| Erica Klinger
Expediting Approval of Generic Applications and Stopping REMS Abuse Among Top Priorities for Nation’s Leading Patient Advocacy Group
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action